Redpoint Ventures is leading a new funding round in Function Health, a personalized lab testing startup, at a $2.5 billion post-money valuation, according to two people familiar with the deal.
The cash injection comes amid VCs’ growing interest in “longevity tech,” with more startups offering personalized preventative testing in the quest to extend human lifespans. Function Health was valued at $191 million when it raised Series A funding in June 2024, according to PitchBook data.
Austin-based Function Health offers a suite of lab tests that scan for early biomarkers of disease. A membership package runs at $499 annually.
Function Health was co-founded by Dr. Mark Hyman, the founder of the Center of Functional Medicine at the Cleveland Clinic and a popular healthcare podcaster and influencer. He is a friend of Robert F. Kennedy Jr., the newly appointed head of the Department of Health and Human Services.
Bloomberg reported Feb. 5 that Function Health was looking to raise $200 million.
The deal is not yet finalized, and terms could still change.
The sector is getting interest despite still being experimental. Prenuvo, a comprehensive MRI testing startup, has not only graced Kim Kardashian’s Instagram page, but has also passed $100 million in revenue in 2024 and recently announced a $120 million round led by Felicis Ventures, Left Lane Capital and Forerunner Ventures.
On the other hand, Forward Health, a concierge healthcare startup backed by Founders Fund and Khosla Ventures to operate AI-enabled “CarePods,” abruptly shut down in November.
Function Health and Redpoint Ventures did not respond to requests for comment.
Learn about our editorial standards.